Background science

Alogna A et al, J Am Coll Cardiol 2024

Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure – PubMed (nih.gov)

Hulot J-S and Kupatt C, J Am Coll Cardiol 2024

Inhalable Therapies for the Heart: Take the “Lung” Way Home? – ScienceDirect

Di Mauro V et al, J Am Coll Cardiol 2023

Diagnostic and Therapeutic Aptamers: A Promising Pathway to Improved Cardiovascular Disease Management | JACC: Basic to Translational Science

Quarta E et al, Journal of Drug Delivery Science and Technology, 2022

Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances – ScienceDirect

Arina P et al, Shock, 2022

Modulation of LTCC Pathways by a Melusin Mimetic Increases Ventricular Contractility During LPS-Induced Cardiomyopathy – PubMed (nih.gov)

Quarta E et al, Pharmaceutics, 2021

Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design – PubMed (nih.gov)

Modica J et al, Circulation, 2021

Nano-miR-133a Replacement Therapy Blunts Pressure Overload-Induced Heart Failure – PubMed (nih.gov)

Di Mauro V et al, Front Physiol, 2021

Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome – PubMed (nih.gov)

Miragoli M et al, Sci Transl Med, 2018

Inhalation of peptide-loaded nanoparticles improves heart failure – PubMed (nih.gov)

Di Mauro V et al, Nanomedicine (Lond), 2016

Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs – PubMed (nih.gov)

Rusconi F et al, Circulation, 2016

Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function – PubMed (nih.gov)